In the HAART era, few clinical studies evaluated prevalence and risk factors of sexual dysfunctions (SD) in HIV-positive men. SD prevalence has been described in up to 74% of this population, but no standardised and validated methods for detection of SD have ever been used. Protease inhibitors and hypogonadism have been inconsistently associated with SD. This is a cross-sectional study to evaluate the prevalence and risk factors of sexual dysfunctions in HIV-infected men.
Sexual dysfunction in HIV-infected men: prevalence and associated factors / Malmusi, D.; Guaraldi, Giovanni; Martinez, E.; de Lazzari, E.; Luzi, K.; Granata, A.; Blanco, J. L.; Orlando, G.; Murri, R.; Gatell, J. M.. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - STAMPA. - 10:8(2005), pp. L58-L58. (Intervento presentato al convegno 7th Intenational Workshop on Aderse Drug reactions and Lipodystrophy in HIV tenutosi a Dublin Ireland nel Nov 13-16, 2005).
Sexual dysfunction in HIV-infected men: prevalence and associated factors
GUARALDI, Giovanni;
2005
Abstract
In the HAART era, few clinical studies evaluated prevalence and risk factors of sexual dysfunctions (SD) in HIV-positive men. SD prevalence has been described in up to 74% of this population, but no standardised and validated methods for detection of SD have ever been used. Protease inhibitors and hypogonadism have been inconsistently associated with SD. This is a cross-sectional study to evaluate the prevalence and risk factors of sexual dysfunctions in HIV-infected men.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
